Presse
Presse
Überschriften über die von uns bewerteten Unternehmen, gesammelt aus öffentlich zugänglichen Nachrichtenquellen. Wir verlinken auf das Original und veröffentlichen es nicht neu — Gefühlsetiketten basieren auf Schlüsselwörtern, nicht auf redaktioneller Beurteilung.
Zeige Berichterstattung für Insulet
28 Überschriften · 1,721 Unternehmen abgedeckt
1–28 von 28
- Insulet stock stands 13.26 percent above its 52-week low - ad-hoc-news.deInsulet· www.ad-hoc-news.de
- Insulet Ordered to Defend Retirement Plan’s Target-Date Funds - Bloomberg Law NewsInsulet· news.bloomberglaw.com
- Insulet’s Omnipod Discover platform sees full market release in US - Fierce BiotechInsulet· www.fiercebiotech.com
- Insulet Announces Omnipod Discover Now Available in U.S.Insulet· finance.yahoo.com
- Insulet Announces Omnipod Discover Now Available in U.S. - Business WireInsulet· www.businesswire.com
- Insulet (PODD) Stock May Trade At A Discount To Fair ValueInsulet· finance.yahoo.com
- Insulet (PODD) Reworked Its Debt, Is The Stock Still Cheap?Insulet· finance.yahoo.com
- BCSM Exits Insulet Corporation (PODD), Maintains Watchlist StatusInsulet· finance.yahoo.com
- 2 S&P 500 Stocks with Impressive Fundamentals and 1 We Turn DownInsulet· finance.yahoo.com
- Beta Bionics’ insulin patch pump gets FDA nodInsulet· medtechdive.com
- Is it Prudent to Retain Insulet Stock in Your Portfolio for Now?Insulet· finance.yahoo.com
- Artisan Sold Insulet (PODD) Due to Competition ConcernsInsulet· finance.yahoo.com
- Why Is Insulet (PODD) Up 8.1% Since Last Earnings Report?Insulet· finance.yahoo.com
- Insulet (PODD) Stock May Be 40% Undervalued On Fair Value GroundsInsulet· finance.yahoo.com